Cargando…
Development of anti-HER2-targeted doxorubicin–core-shell chitosan nanoparticles for the treatment of human breast cancer
Purpose: Doxorubicin (DOX) encapsulated O-succinyl chitosan graft Pluronic(®) F127 (OCP) copolymer nanoparticles conjugated with an anti-HER2 monoclonal antibody were developed as targeted drug delivery vehicles for the treatment of HER2-overexpressing breast cancer. Methods: Five percent and 10% (w...
Autores principales: | Naruphontjirakul, Parichart, Viravaidya-Pasuwat, Kwanchanok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557189/ https://www.ncbi.nlm.nih.gov/pubmed/31239670 http://dx.doi.org/10.2147/IJN.S198552 |
Ejemplares similares
-
Inclusion of IR-820 into Soybean-Phosphatides-Based Nanoparticles for Near-Infrared-Triggered Release and Endolysosomal Escape in HaCaT Keratinocytes at Insignificant Cytotoxic Level
por: Homsirikamol, Chaiyarerk, et al.
Publicado: (2020) -
Controlled Release Mechanism of Vancomycin from Double-Layer Poly-L-Lactic Acid-Coated Implants for Prevention of Bacterial Infection
por: Thamvasupong, Papon, et al.
Publicado: (2022) -
Injectable Poly(ethylene glycol) Hydrogels Cross-Linked
by Metal–Phenolic Complex and Albumin for Controlled Drug Release
por: Bubpamala, Theeraporn, et al.
Publicado: (2020) -
Expansion of fibroblast cell sheets using a modified MEEK micrografting technique for wound healing applications
por: Benchaprathanphorn, Kanokaon, et al.
Publicado: (2022) -
Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab
por: Yousefpour, Parisa, et al.
Publicado: (2011)